Why big pharma's paying attention to drug delivery

There are a great many market reports being sold out there, but a new one on drug delivery by Insight Pharma that might be worth a look. Advanced Drug Delivery Technologies: Enabling Drug Reformulations and Administration Routes seems to touch on all the major trends and issues in drug delivery. The report notes, correctly, that big pharma companies are paying more attention to drug delivery companies by finding new uses for known active ingredients. It discusses drug-delivery applications of nanotech, nucleic acid delivery, the resurgence of transdermal delivery technology, the role of alternative delivery in drug lifecycle management. Abstract

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.